statistiche ricercatore

Continente	#
NA - Nord America	1.675
EU - Europa	647
AS - Asia	555
SA - Sud America	80
Continente sconosciuto - Info sul continente non disponibili	23
AF - Africa	18
OC - Oceania	1
Totale	2.999

Nazione	#
US - Stati Uniti d'America	1.651
IT - Italia	217
SG - Singapore	187
GB - Regno Unito	143
CN - Cina	103
VN - Vietnam	72
HK - Hong Kong	68
SE - Svezia	68
BR - Brasile	62
DE - Germania	46
FR - Francia	37
BD - Bangladesh	29
RU - Federazione Russa	29
FI - Finlandia	26
TR - Turchia	25
UA - Ucraina	17
ID - Indonesia	14
IN - India	13
BG - Bulgaria	10
CA - Canada	9
ES - Italia	9
KR - Corea	9
CZ - Repubblica Ceca	8
AR - Argentina	7
NL - Olanda	7
BE - Belgio	6
IQ - Iraq	6
JP - Giappone	6
MX - Messico	6
ZA - Sudafrica	6
LT - Lituania	5
MY - Malesia	5
MA - Marocco	4
PL - Polonia	4
AE - Emirati Arabi Uniti	3
AT - Austria	3
IR - Iran	3
VE - Venezuela	3
AZ - Azerbaigian	2
BA - Bosnia-Erzegovina	2
CO - Colombia	2
CR - Costa Rica	2
DZ - Algeria	2
IE - Irlanda	2
JM - Giamaica	2
KE - Kenya	2
KG - Kirghizistan	2
PE - Perù	2
PH - Filippine	2
RS - Serbia	2
SA - Arabia Saudita	2
SK - Slovacchia (Repubblica Slovacca)	2
TN - Tunisia	2
UY - Uruguay	2
AU - Australia	1
BB - Barbados	1
BH - Bahrain	1
BZ - Belize	1
CH - Svizzera	1
CL - Cile	1
EC - Ecuador	1
EG - Egitto	1
EU - Europa	1
GD - Grenada	1
HN - Honduras	1
JO - Giordania	1
LA - Repubblica Popolare Democratica del Laos	1
MD - Moldavia	1
NO - Norvegia	1
PA - Panama	1
PK - Pakistan	1
SD - Sudan	1
SI - Slovenia	1
Totale	2.977

Nome	#
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes	475
A 5-year clinical follow-up study from the Italian National Registry for FSHD	397
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry	377
Large scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy (FSHD)	339
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy.	329
The Italian FSHD registry: An enhanced data integration and analytics framework for smart health care	296
Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis	281
D4Z4 reduced allele in myopathic subjects with no FSHD phenotype: why inconsistency between molecular and clinical data should prompt us to further investigations.	273
Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy	232
Totale	2.999

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	276	11	16	55	10	12	13	17	23	30	15	53	21
2022/2023	276	28	33	25	18	49	24	6	26	28	1	20	18
2023/2024	182	2	11	11	16	22	11	11	22	8	13	9	46
2024/2025	441	18	17	7	32	78	67	27	51	54	16	29	45
2025/2026	813	48	19	45	91	145	66	120	29	73	73	64	40
2026/2027	23	23	0	0	0	0	0	0	0	0	0	0	0
Totale													2.999